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http://dx.doi.org/10.1016/j.devcel.2016.01.005Neuroblastomas are associated with KIF1Bbmutations within tumor suppressor region 1p36. In this issue of
Developmental Cell, Li et al. (2016) show that KIF1Bb binding releases calcineurin autoinhibition, leading to
dephosphorylation of the DRP1 GTPase and subsequent mitochondrial fragmentation. KIF1Bb impairment
causes mitochondrial hyperfusion, impairing developmental apoptosis and promoting tumorigenesis.During development of the sympathetic
nervous system, neural progenitor cells
depend on nerve growth factor (NGF) for
regulation of differentiation and survival.
Excess progenitors are normally limited
through apoptosis when NGF becomes
limiting during development, and tumors
such as neuroblastoma and pheochro-
mocytoma can arise when neural progen-
itors fail to die under these conditions.
Analyses of familial forms of these can-
cers have identified alterations in the suc-
cinate dehydrogenase genes SDHB,
SDHC, and SDHD, as well as in VHL,
RET, and NF1. All of these genes encode
products that regulate an NGF-depen-
dent signaling pathway influencing
neuronal survival. This pathway ultimately
links the NGF receptor (TrkA) to the prolyl
hydroxylase EGLN3, which is required for
apoptosis upon NGF withdrawal (Lee
et al., 2005). Thus, a failure to properly
cull unwanted cells during development
appears to predispose cells to oncogenic
transformation. Suppression of neural
crest-derived tumors such as neuroblas-
toma and pheochromocytoma has long
been linked to a critical region in the distal
short arm of chromosome 1 (1p36) that is
deleted in a number of human malig-
nancies. Understanding themolecular ba-
sis for this suppression has been an area
of intense interest for decades.
Previous work scrutinizing 1p36 (Hen-
rich et al., 2012) has highlighted the
possible involvement of several genes in
the region. The chromatin remodeler
CHD5, which is crucial for neuronal differ-
entiation via dual roles in facilitating gene
expression and polycomb gene repres-
sion (Egan et al., 2013), is one candidate.
More recently, particular interest hasfocused on loss-of-function mutations in
KIF1B, a gene encoding members of the
kinesin-3 family of motor proteins. KIF1B
encodes two alternatively spliced iso-
forms, KIF1Ba and KIF1Bb. The isoforms
share the same N-terminal motor domain
but differ in their C-terminal cargo do-
mains, and they are differentially involved
in transport of mitochondria (KIF1Ba) and
synaptic vesicle precursors (KIF1Bb).
KIF1Bb, but not KIF1Ba, has also surpris-
ingly been implicated in NGF-mediated
neuronal apoptosis independent of its
motor functions, prefiguring an unex-
pected role in sympathetic nerve develop-
ment. In fact, though found in only a small
percentage of neural crest tumors overall,
a number of different KIF1B variants iden-
tified in tumors clearly impair KIF1Bb
function in studies in vitro, and one
missense mutation segregated across
three generations of a cancer-prone fam-
ily with a number of neural and non-neural
malignancies (Yeh et al., 2008). Recently,
Chen et al. (2014) reported that KIF1Bb in-
teracts with RNA helicase A (DHX9),
causing nuclear accumulation of DHX9
and subsequent induction of proapopto-
tic XIAP-associated factor 1 (XAF1), ulti-
mately leading to apoptosis.
In this issue of Developmental Cell, Li
et al. (2016) provide an additional mecha-
nism to explain the effects of KIF1Bb on
tumorigenesis. These authors found that
KIF1Bb activates the Ca2+-calmodulin-
dependent protein phosphatase calci-
neurin by binding and stabilizing the
calmodulin-calcineurin complex, relieving
enzymatic autoinhibition (more com-
pletely than Ca2+ alone) and permitting
substrate recognition broadly. This result
is quite daunting upon initial consider-Developmental Cell 3ation, since calcineurin is a ubiquitous
mediator of cellular responses to Ca2+
signaling—with many substrates—and
its dysregulation has already been impli-
cated in a host of immune, neurodegener-
ative, and oncologic disorders. Impor-
tantly, out of the panoply of known
calcineurin substrates, Li et al. (2016)
focused on a critical role for calcineurin-
dependent activation of DRP1, a dyna-
min-related, multimeric GTPase that
mediates mitochondrial fission, a critical
event during apoptosis. The authors
found that KIF1Bb affects mitochondrial
morphology through calcineurin-de-
pendent dephosphorylation of DRP1
Ser637, which is phosphorylated by pro-
tein kinase A (PKA). This regulated
dephosphorylation is known to promote
translocation of DRP1 to the mitochon-
drial surface, where it catalyzes mito-
chondrial fission (Cereghetti et al., 2008)
(Figure 1). Under normal cellular condi-
tions, over 95% of DRP1 is cytoplasmic,
so this translocation is a key activation
step. DRP1 opposes the activities of
several intrinsic large mitochondrial
GTPases (MFN1/2 and OPA1) that
mediate mitochondrial fusion, and thus
disruption of DRP1 function leads tomito-
chondrial hyperfusion. Imbalances in
mitochondrial morphology have been
seen inmany diseasemodels, and several
of these GTPases regulating mitochon-
drial morphology (including DRP1) are
mutated in neurologic disorders, empha-
sizing the importance of proper mitochon-
drial morphology for cellular health (Chan,
2012).
But how does mitochondrial hyperfu-
sion relate specifically to tumor forma-
tion? Li et al. (2016) tested multiple known6, January 25, 2016 ª2016 Elsevier Inc. 127
Figure 1. Model of KIF1Bb-Dependent Effects on Mitochondrial Fission/Fusion Balance in
NGF-Limiting Conditions
KIF1Bb activates calcineurin (CN) by relieving autoinhibition, resulting in dephosphorylation of DRP1
Ser637. This triggers DRP1 translocation to mitochondria and subsequent division, leading to cytochrome
c release (stars), apoptosis, and cell death. In the absence of KIF1Bb, DRP1 Ser637 is phosphorylated (P)
by PKA and remains modified. Mitochondrial fission is impaired, resulting in mitochondrial hyperfusion,
aberrant cell survival, and promotion of tumorigenesis. Figure adapted from Anderson and Blackstone
(2013).
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in neuroblastomas and pheochromocy-
tomas, and all failed to activate calci-
neurin or stimulate DRP1 dephosphoryla-
tion. In addition, all seven hemizygous
KIF1Bb-deleted neuroblastomas exam-
ined had silencing of both DRP1 and
KIF1Bb—in stark contrast to 1p36 intact
tumors—and low expression of these
genes correlated with poor prognosis
and reduced survival in neuroblastoma
patients (Li et al., 2016). Moreover, deple-
tion of DRP1 blocked KIF1Bb-mediated
apoptosis in NB1 neuroblastoma cells,
and PKA gain-of-function tumorigenic
mutations (expected to enhance phos-
phorylation at DRP1 Ser637 and inhibit
mitochondrial fission) blocked KIF1Bb-in-
duced apoptosis as well. Together, these
data provide compelling evidence for a128 Developmental Cell 36, January 25, 201critical role of impaired mitochondrial
fission/fusion balance in high-risk and
poor-prognosis neuroblastomas and
further identify this process as a potential
therapeutic target. However, it seems
likely that other mechanisms may also
contribute. Indeed, this calcineurin-
dependent pathogenic mechanism has a
clear link to the role of KIF1Bb loss of
function in impairing DHX9 nuclear locali-
zation (Chen et al., 2014), since the calci-
neurin docking motif (LXVP) in DRP1
(Slupe et al., 2013) is also present in
DHX9, and calcineurin binds DHX9 only
in the presence of KIF1Bb (Li et al., 2016).
Since the first report of 1p36 deletions
in neuroblastomas four decades ago, de-
letions in this region have been linked to
wide range of tumors, extending well
beyond those of the neural crest. The6 ª2016 Elsevier Inc.tumorigenic role of KIF1Bb loss of func-
tion is becoming more and more compel-
ling, but other nearby 1p36 genes such as
CHD5, CAMTA1, CASZ1, and miR-34a
may also be altered in dosage (Henrich
et al., 2012), and disruptions in a number
of these genes may work in synergy with
one another, as well as with KIF1Bb (in
cells that express KIF1Bb) to promote
tumorigenesis. The non-motor roles
played by KIF1Bb in unexpected cellular
locales continue to surprise.REFERENCES
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